Why are Lipid Formulations Commonly Used to Enhance Bioavailability?

Enabling formulations becomes more and more necessary to obtain adequate exposure of APIs during (pre)-clinical research. Currently, most registered formulations to improve bioavailability are based on lipidic systems, which make use of intrinsic digestion processes within the GI tract, facilitating the absorption of APIs. Aside from a general absorption mechanism, lipidic systems can also promote lymphatic transport of poorly soluble drugs, such as hormones. In addition, many different indications, such as HIV therapy, oncology, immunosuppressant and even arising therapies related to medicinal cannabis (e.g. CBD) can benefit from lipid formulations. These formulations create multiple possibilities for oral administration because they can be manufactured as solutions, suspensions, emulsions, and self-(micro)emulsifying systems.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

What the food supply chain can learn from the pharma industry.

Controlant

With the increase and complexity of the global supply chain, both the pharmaceutical cold chain and temperature-controlled shipping for the food and beverage industry have seen substantial growth over the last few years. It is no coincidence that the food industry is now beginning to look to the pharmaceutical supply chain for guidance on best practices, as the need for stricter standardization and controls has emerged.
Watch Now

EU Medical Device Regulation: Your Questions Answered

Premier Research

This webinar will address these and other critical questions and will pave the way to strategic planning for compliance with the EU MDR. New product development teams will discover that the timeline for MDR is extremely limited compared to existing products on the market. Post-market surveillance teams will discover the implications of the Post-Market Clinical Follow-up requirement and the European Database on Medical Devices.
Watch Now

Document Imaging and Medical Record Management

Lorman

Many Health Information Management departments are still prepping charts that come from all departments of a hospital system. This means that there is a potential time lag in making this critical information available to providers. The first place to start is selecting a document imaging solution for any paper being produced outside of your EMR system. But let's take this a step further. What if we move document imaging out of the HIM department and into each clinical area of a hospital?
Watch Now

Applying Technology to New Science: Biopharma’s New Growth Engine

fiercepharma

Today, there are clear signs that the biopharmaceutical industry is facing a quiet yet potentially damaging force: compressive disruption. However, future-focused biopharma companies have found a way to deliver exceptional growth amidst compressive disruption: by embracing New Science, an ever-evolving combination of the best in science and health technology that is filling unmet need and raising the standard of care. Accenture research finds that leaders in New Science are investing 6-7x more in digital, data and genomics compared to their peers.
Watch Now